EligibleTrials

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Recruiting · NCT04983823 · Interventional (participants receive a specific treatment) · Lead sponsor: Baker Heart and Diabetes Institute

View the official record on ClinicalTrials.gov →
Heart Failure

Interventions studied

Heart Failure intervention (Cardiac COVID Disease Management Plan (CC-DMP)Usual care

What this trial is about

This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.

Who can take part

Age range
50 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.